Clinical Research Directory
Browse clinical research sites, groups, and studies.
4 clinical studies listed.
Filters:
Tundra lists 4 Median Nerve Compression clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.
This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.
NCT07741708
Kinesio Taping for Pain, Median Nerve Morphology, and Quality of Life in Patients With Carpal Tunnel Syndrome
Carpal tunnel syndrome is a common condition caused by compression of the median nerve at the wrist. It can result in pain, numbness, tingling, weakness, and difficulty performing daily activities. Conservative treatments, including therapeutic exercises and kinesio taping, are frequently used; however, evidence regarding the effects of kinesio taping on both nerve morphology and clinical outcomes remains limited. The purpose of this randomized controlled trial is to evaluate whether adding kinesio taping to a standard exercise program provides greater benefits than exercise alone in patients with carpal tunnel syndrome. Participants will be randomly assigned to one of two groups: an intervention group receiving kinesio taping plus nerve and tendon gliding exercises, or a control group receiving the exercise program alone. Outcome measures include ultrasonographic assessment of the median nerve anteroposterior and transverse diameters, pain intensity measured with the Visual Analog Scale (VAS), and symptom severity and functional status evaluated using the Boston Carpal Tunnel Questionnaire. Assessments will be performed before treatment and after the 4-week intervention period. The findings of this study are expected to provide evidence regarding the effectiveness of kinesio taping as an adjunct to conservative rehabilitation for individuals with carpal tunnel syndrome and may contribute to improving treatment strategies for this condition.
Gender: All
Ages: 25 Years - 65 Years
Updated: 2026-08-03
1 state
NCT07508397
Median Nerve Cross-Sectional Area and Body Weight in Carpal Tunnel Syndrome
This study aims to evaluate the diagnostic accuracy of ultrasonographic measurements of the median nerve in patients with Carpal Tunnel Syndrome (CTS). While ultrasound is a common diagnostic tool, various physical factors can influence its results. The researchers will investigate how a patient's absolute body weight and Body Mass Index (BMI) affect the size of the median nerve cross-sectional area across different stages of disease severity. The goal is to determine if absolute body weight plays a 'masking' role that could lead to more precise diagnostic interpretations in clinical practice.
Gender: All
Ages: 18 Years - 75 Years
Updated: 2026-04-02
NCT07484100
Efficacy of Proximal Median Nerve Release
A multi-center randomized controlled clinical trial which determines the efficacy of proximal median nerve release in patients with persistent proximal median nerve compression. The primary outcome is patient reported improvement of symptoms on a 7-point Likert scale at 6 months after the randomization to treatment group.
Gender: All
Ages: 18 Years - Any
Updated: 2026-03-19
NCT07435961
Magnetotherapy in Carpal Tunnel Syndrome: Randomized Controlled Study
This study is designed to investigate the effectiveness of low-frequency pulsed electromagnetic field therapy in individuals diagnosed with mild-to-moderate carpal tunnel syndrome (CTS). This double-blind, randomized controlled trial will randomly assign participants into three groups: Group 1: Active magnetotherapy Group 2: Placebo magnetotherapy (treatment using an identical device that does not generate a magnetic field) Group 3: Routine (conservative) treatment group All participants will receive a standard nighttime wrist splint and a standardized nerve and tendon gliding exercise protocol. Magnetic field applications will be administered five days per week for a total of 15 sessions. Assessments will be conducted at baseline (T0), at the end of treatment (T1 - Week 3), at 1 month (T2), and at 3 months (T3). The primary outcome measures include the Boston Carpal Tunnel Questionnaire (BCTQ), pain intensity assessed by the Visual Analog Scale (VAS), functional status measured by QuickDASH, median nerve cross-sectional area assessed by ultrasonography, sensory function evaluated using the Semmes-Weinstein monofilament test, grip strength measured by dynamometry, and clinical test results (Tinel and Phalen tests). Secondary outcomes include sleep quality assessed by the Pittsburgh Sleep Quality Index (PSQI) and patient satisfaction. This study aims to contribute to the scientific evidence regarding the effectiveness of magnetotherapy as a non-invasive treatment option for carpal tunnel syndrome.
Gender: All
Ages: 18 Years - 65 Years
Updated: 2026-02-27
1 state